Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. Medanta provides healthcare services in over 30 medical specialties and engages over 1,800 doctors. Its specialty treatments are in cardiac care, cancer care, neurosciences, orthopedics, renal care, liver transplants, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, ENT, head and neck surgery, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, homecare services, health checkups, elder care, air ambulance, among others. Its subsidiaries include Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.As of 26 May 2026, Global Health share price is ₹1,249.00. The stock opened at ₹1,254.70, compared to its previous close of ₹1,238.10. During today's trading session, Global Health share price moved in the range of ₹1,236.60 to ₹1,266.50, with an average price of ₹1,251.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,236.60 and a high of ₹1,266.50. On the performance front, Global Health share price has declined by 0.02% over the last six months and is up 2.41% on a year-on-year basis.
The market capitalization of Global Health is ₹33,297 Crs, with a P/E ratio of 60.1 and a dividend yield of 0.00%.